ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2040

T Follicular Helper like CD4+CXCR5+pd-1+ Cells and T Follicular Helper like Type 2 Cells Subsets Are Increased in IgG4-Related Disease Patients

Aurélie Grados1, Mikael Ebbo1, Christelle Piperoglou2, Matthieu Groh3, Alexis Regent4, Maxime Samson5, Benjamin Terrier6, Nathalie Morel7, Sylvain Audia5, Francois Maurier8, Julie Graveleau9, Mohamed Hamidou10, Amandine Forestier11, Sylvain Palat12, Emanuelle Bernit1, Gilles Kaplanski13, Frederique Retornaz14, Bernard Bonotte15, Catherine Farnarier16, Jean-Robert Harle17, Nathalie Costedoat-Chalumeau7, Frederic Vely18 and Nicolas Schleinitz1, 1Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, 2Immunology, CIML, AP-HM, Marseille, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 4Service de médecine interne, Hôpital Cochin, Paris, France, 5Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, 6Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France, 7Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 8Medecine Interne, Metz, France, 9Medecine Interne Hotel Dieu Nantes, Nantes, France, 10Internal Medicine Department, Nantes University Hospital, Nantes, France, 11Internal Medicine, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France, 12Service de Medecine Interne, CHU limoges, Limoges, France, 13Internal Medicine hopital conception, Aix-Marseille Université, Marseille, France, 14Conseil General 13 cellule recherche, Marseille, France, 15Department of Internal medicine and Clinicla Immunology Dijon University Hospital, Dijon, France, 16Laboratoire d'immunologie, Hopital de la Conception, Marseille, France, 17Internal Medicine, Aix-Marseille Université, APHM, Marseille, France, 18CIML, Laboratoire d'Immunologie Conception AP-HM, Aix-Marseille université, Marseille, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: IgG4 Related Disease, Plasmablasts, T cells and cytokines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Miscellaneous Rheumatic and Inflammatory Diseases Oral Session II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

IgG4 related disease (IgG4-RD) is associated with characteristic pathological changes including lymphoplasmocytic infiltration with abundant IgG4 positive plasma cells, storiform fibrosis and obliterative phlebitis. Recently an increase of plasmablasts in blood has been correlated with IgG4-RD activity. In IgG4-RD lesion tissues, germinal centers (GC) are often observed and could be source of plasmablasts. T follicular helper (Tfh) cells orchestrate antigen driven GC formation and B cell differentiation. Bona fide Tfh cells have been initially recognized in lymph nodes but a circulating counterpart characterized as Tfh like CD4+CXCR5+PD-1+ cells has been reported. We analyzed the Tfh like cells and their subsets in blood of untreated IgG4-RD patients.

Methods:

Thirty patients with IgG4-RD were included prospectively in the study and compared to matched (age and gender) healthy controls (HC) and matched (age) primary Sjögren syndrome (pSS) patients. Patients fulfilled the 2011 comprehensive IgG4-RD diagnostic criteria and the 2002 American-European Consensus Group criteria for pSS. Peripheral blood mononuclear cells (PBMC) of patients and controls were analyzed by flow cytometry on a BD FACS Canto II. Tfh like cells were defined as CD4+CXCR5+PD-1+. Subsets of Tfh were defined as Tfh2 CCR6–CXCR3­- , Tfh-1 CCR6–CXCR3­+ and Tfh-17 CCR6+CXCR3­-. The cytokine production by PBMC for IL-4, IL-10 and IL-17 was performed with the cytokine bead assay (CBA® kit, BD Biosciences). Statistical analysis was performed on PRISM software.

Results: The frequency and absolute numbers (AN) of CD4+CXCR5+PD-1+Tfh like cells are increased in IgG4-RD when compared to HC (p<0,001) and pSS (p<0,001). In contrast the frequency (p=0.1) and AN (p=0.2) of CD4+CXCR5+ is not different from HC. Tfh-1 were decreased in IgG4-RD when compared to HC (p=0.0005) and pSS (p=0.002). Tfh-17 frequency only differed between IgG4-RD and pSS (p=0.04), increased in pSS. Tfh-2 were significantly increased in IgG4-RD when compred to HC (p<0.0001) and pSS (p=0.01). Tfh-2 values correlated with IgG4 serum levels (p=0.03) and IL-4 production by CBA assay (p=0.01) but not with IgG4-RD responder index (p=0.4) and plasmablasts numbers (p=0.1).  

Conclusion: IgG4-related disease is associated with increased levels of T Follicular helper like CD4+CXCR5+PD-1+ cells in blood. The increase of Tfh like cells is mainly related to an increase of the Tfh2 CCR6–CXCR3­- subset. These finding suggests that T follicular helper 2 cells, characterized by their ability to produce Th2 cytokines, play a role in IgG4-RD pathogenesis.


Disclosure: A. Grados, None; M. Ebbo, None; C. Piperoglou, None; M. Groh, None; A. Regent, None; M. Samson, None; B. Terrier, None; N. Morel, None; S. Audia, None; F. Maurier, None; J. Graveleau, None; M. Hamidou, None; A. Forestier, None; S. Palat, None; E. Bernit, None; G. Kaplanski, None; F. Retornaz, None; B. Bonotte, None; C. Farnarier, None; J. R. Harle, None; N. Costedoat-Chalumeau, None; F. Vely, None; N. Schleinitz, CSL behring Company France, 2,Roche France, 2,GlaxoSmithKline france, 2.

To cite this abstract in AMA style:

Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Kaplanski G, Retornaz F, Bonotte B, Farnarier C, Harle JR, Costedoat-Chalumeau N, Vely F, Schleinitz N. T Follicular Helper like CD4+CXCR5+pd-1+ Cells and T Follicular Helper like Type 2 Cells Subsets Are Increased in IgG4-Related Disease Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/t-follicular-helper-like-cd4cxcr5pd-1-cells-and-t-follicular-helper-like-type-2-cells-subsets-are-increased-in-igg4-related-disease-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-follicular-helper-like-cd4cxcr5pd-1-cells-and-t-follicular-helper-like-type-2-cells-subsets-are-increased-in-igg4-related-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology